Shukra Pharmaceuticals Q3 Results
- BSE: 524632
- NSE: SHUKRAPHAR
- ISIN: INE551C01044
- Sector: Biotechnology & Drugs
BSE
41.43
0.18 (0.44%)
0.18 (0.44%)Volume1.25 M
Updated: Fri 14 Aug, 2026 | 15:56:38
NSE
41.42
0.00 (0.00%)
0.00 (0.00%)Volume1.11 M
Updated: Fri 14 Aug, 2026 | 15:56:38
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Shukra Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 25 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 12.84 | 7.11 | 80.64% |
| Depreciation/ Amortization | 0.84 | 0.81 | 3.65% |
| Operating Income | 26.30 | -1.23 | 0.00% |
| Net Income | 20.36 | 2.38 | 756.38% |
| Other Operating Expenses Total | 2.22 | 2.10 | 5.63% |
| Net Income Before Taxes | 26.83 | 0.20 | 13423.94% |
| Total Revenue | 39.13 | 5.88 | 565.85% |
| Selling/ General/ Admin Expenses Total | 2.65 | 2.19 | 20.69% |
| Diluted Normalized EPS | 0.47 | 0.05 | 840.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.